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Summary. Two-dimensional electrophoresis (isoelectric focusing/SDS-PAGE) and Western-blotting techniques were used to
analyze and compare common and/or specific outer-membrane proteins and antigens from Neisseria meningitidis and Neisseria
lactamica. Bioinformatic image analyses of proteome and immunoproteome maps indicated the presence of numerous proteins
and several antigens shared by N. meningitidis and N. lactamica, although the inter-strain variation in the maps was of similar
magnitude to the inter-species variation, and digital comparison of the maps did not reveal proteins found to be identical by
MALDI-TOF fingerprinting analysis. PorA and RmpM, two relevant outer-membrane antigens, manifested as various spots at
several different positions. While some of these were common to all the strains analyzed, others were exclusive to N. meningi-
tidis and their electrophoretic mobilities were different than expected. One such spot, with a molecular mass of 19 kDa, may be
the C-terminal fragment of RmpM (RmpM-Cter). The results demonstrate that computer-driven analysis based exclusively on
spot positions in the proteome or immunoproteome maps is not a reliable approach to predict the identity of proteins or antigens;
rather, other identification techniques are necessary to obtain accurate comparisons. [Int Microbiol 2007; 10(1):5-11]
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Introduction
Considerable research effort has been dedicated to the devel-
opment of vaccines able to confer protection against
meningococcal meningitis and showing long-term immuno-
logical memory as well as wide cross-reactivity. Conjugated
vaccines against serogroup C have been some of the most
important achievements to date [8], but efforts to develop
vaccines against serogroup B have been less successful,
despite recent advances [10,14]. Vaccines based on outer-
membrane vesicles were developed in Cuba and Norway in
the 1980s in response to disease outbreaks in those countries
[2,15]; however, they have only been useful against homolo-
gous strains. For this reason, there is great interest in the
identification of conserved antigens able to induce functional
bactericidal antibodies, such as those involved in the devel-
opment of naturally acquired immunity [4]. Epidemiological
evidence suggests that the non-pathogenic Neisseria lactam-
ica may be involved in natural immunity, and it is likely that
the use of antigens from this species in vaccines would be
effective against N. meningitidis [9,18].
One-dimensional SDS-PAGE combined with mass spec-
trometry has proven to be very efficient for the resolution
and identification of the proteins present in meningococcal
outer-membrane vesicles [11,19–21]. Nevertheless, identifi-
cation and analysis of single antigenic proteins in these vesi-
cles requires two-dimensional separation techniques to
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obtain immunoproteome maps that can be used to assess the
efficacy of vaccine formulations containing specific anti-
gens. The aim of this study was to determine the usefulness
of two-dimensional electrophoresis (isoelectric focusing
/SDS-PAGE) combined with Western-blotting in the identifi-
cation and analysis of the cross-reactivity of outer-membrane
antigenic proteins from N. meningitidis and N. lactamica. 
Materials and methods
Bacterial strains and outer-membrane vesicles. Three
N. meningitidis and three N. lactamica strains were used in this work. N.
meningitidis strains B16B6 (B:2a:P1.5,2; ST-11/ET-37), M982 (B:9:P1.9;
ST-5), and Nm30 (C:2b:P1.2,5; ST-8/Cluster A4) were isolated from the
cerebrospinal fluid of patients suffering from meningococcal meningitis.
The first two are reference strains, whereas the third is from our laboratory
collection. N. lactamica strains NlP0, NlP2, and NlP5 were isolated from
the oropharynx of volunteers in our community. The strains were main-
tained and cultured as described previously [13]. All bacteria were cultured
under iron restriction in Mueller-Hinton (MH) broth containing 100 μM
Desferal. Outer-membrane vesicles (OMVs) were obtained as described
previously [13].
Immune sera. Mouse immune sera against OMVs from N. meningitidis
strains Nm30 and B16B6 and N. lactamica strains NlP2 and NlP5 were
obtained by intraperitoneal injection of CBA mice [12]. Monoclonal serum
(mAb 185,H-8 ) specific for the RmpM protein was kindly donated by Dr.
Einar Rosenqvist (National Institute of Public Health, Oslo, Norway).
Monoclonal serum against a conserved epitope in the PorA protein (mAb 9-
1-P-1.c) was kindly provided by Elizabeth Moran (Walter Reed Army
Institute, USA). Two rabbit sera, one against OMVs from N. meningitidis
strain Nm30 and the other against a purified 47-kDa outer-membrane protein
(P47; locus NMB0035), were obtained in our laboratory [1].
Two-dimensional electrophoresis. OMVs (1 μg/μl) for two-
dimensional electrophoresis were solubilized in a solution of 5 M urea, 2 M
thiourea, 2 mM tributyl phosphine (TBP), 2% (w/v) 3[(3-cholamido-
propyl)dimethylammonio]-propanesulfonic acid (CHAPS), 2% (w/v) N-
decyl-N,N-dimethyl-3-ammonio-1-propanesulfonate (SB 3-10), 0.2% (v/v)
Bio-lyte 3/10 (Bio-Rad, Richmond, VA, USA), 40 mM Tris, and 0.0002%
(v/v) bromophenol blue. For the first dimension, sample (125 μl) was loaded
in a 7-cm immobilized pH gradient (IPG) strip (pH 3–10), and actively rehy-
drated by applying 50 V at 20ºC for 16 h in a Protean IEF cell (Bio-Rad).
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Fig. 1. Coomassie-blue-stained 2-D protein maps of Neisseria meningitidis strain B16B6 (A), and N. lactamica NlP0 (B), and the pre-
dicted common spots maps obtained for all N. meningitidis (C) and N. lactamica (D) strains analyzed. Dashed line indicates a PorA
spot train. Numbers indicate relevant spots identified by MALDI-TOF (see Tables 1 and 2).
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Isoelectric focusing was conducted using a three-step program: (i) linear
voltage increase from 0 to 500 V over 20 min, (ii) linear voltage increase
from 500 to 4000 V over 4 h, and (iii) focusing until 10,000 V-h were
reached (at a maximum of 4000 V). Before the samples were separated in the
second dimension, the IPG strip was equilibrated first in a solution contain-
ing 6 M urea, 2% (w/v) SDS, 0.05 M Tris/HCl (pH 8.8), 20% (v/v) glycerol,
and 2% (w/v) dithiothreitol (DTT) and then in a solution containing 6 M
urea, 2% (w/v) SDS, 0.05 M Tris/HCl (pH 8.8), 20% (v/v) glycerol, and
2.5% (w/v) iodoacetamide. Separation in the second dimension was carried
out by SDS-PAGE in 9–18% acrylamide gradient gels using a Mini-PRO-
TEAN 3 Cell (Bio-Rad). The separated proteins were visualized by
Coomasie staining.
Detection and identification of proteins and antigens.
Some of the proteins were identified by MALDI-TOF analysis of the most
relevant spots (those more clearly visible and common to all strains ana-
lyzed), which were excised from the 2-D gels. The antigenic patterns and
immunological identification of some of the antigens were determined by
transferring two-dimensional electrophoresis gels to polyvinylidene fluoride
(PVDF) membranes using a Mini-Trans-Blot Electrophoretic transfer cell
(Bio-Rad) according to the manufacturer’s instructions. Membranes were
then sequentially probed with the above-listed sera, and bound immunoglob-
ulins were visualized with peroxidase-conjugated antibodies in combination
with standard colorimetric techniques.
Image analysis. Stained gels and PVDF membranes were scanned with
a GS-800 densitometer, and image analysis was done using PDQuest 7.2
software (Bio-Rad). Images were improved by the application of a weight-
ed-mean (3´3 pixel matrix) noise-reduction filtering algorithm. Protein spots
were then detected and gaussian images created for each spot. Proteomic and
immunoproteomic maps from OMV preparations obtained on at least three
different days were used to construct reference maps for each strain. Data
analysis for comparisons was done using the most restrictive matching
method provided in the software.
Results
Stringent solubilization conditions and conventional 2-D
analysis (IEF/SDS-PAGE) were used to obtain reference pro-
teome maps. Figure 1 shows the maps for strains N. meningi-
tidis B16B6 (Fig. 1A) and N. lactamica NlP2 (Fig. 1C). Two
main “trains” of spots (at various points in the pI range, with
the same molecular masses), corresponding to PorA (42 kDa)
and RmpM (36 kDa), were detected in the N. meningitidis
strains. As shown in Fig. 1B, the software identified a total of
OUTER MEMBRANE PROTEOMES
Table 1. MASCOT search results obtained by MALDI-TOF analysis of relevant spots of the Neisseria meningitidis master strain (B16B6)
Molecular mass Isoelectric point
Spot GenBank accession  number Protein name Observed Predicted Observed Predicted
1 CAA61894 OMP P64k61.0 61.0 62.2 6.4 5.4
2 P42385 60-kDa chaperonina 66.4 57.5 7.0 5.0
3 CAB83479 Putative periplasmatic protein 47.7 45.6 5.5 7.8
4 CAA40469 Class 1 OMP (PorA) 42.8 42.8 4.8 4.8
5 AAD52970 Class 1 OMP (PorA) 43.7 43.7 5.3 5.3
6 CAA40469 Class 1 OMP (PorA) 41.2 41.2 5.6 5.6
7 CAA46064 Major ferric-iron-binding proteina 35.7 35.8 7.1 9.6
8 1904330A Ferric iron-binding proteina 31.6 33.5 7.3 9.5
9 A37004 Class 4 OMP (RmpM)a 31.2 26.2 5.3 6.5
10 A37004 Class 4 OMP (RmpM)a 33.7 26.2 6.0 6.5
11 CAB85320 Class 4 OMP (RmpM)a 33.5 26.3 6.1 7.0
12 CAB85353 Hypothetical protein 27.5 27.3 6.3 5.6
13 CAB85420 Putative thiol:disulfide interchange proteina 27.3 25.4 7.1 5.8
14 CAB85036 Histidine-binding periplasmatic proteina 27.6 29.1 7.5 5.2
15 CAB85036 Histidine-binding periplasmatic proteina 29.0 29.1 7.6 5.2
16 AAF40732 Thiol:disulfide interchange protein DsbAa 24.6 25.4 7.1 5.8
17 D81800 Probable peptidil-propyl isomerase 22.8 28.9 7.5 5.7
18 AAF41888 Putative peptidil-propyl isomerase 19.7 28.9 6.0 5.7
19 A81072 Azurin precursor 19.8 18.7 7.4 4.8
20 A81072 Azurin precursor 19.8 18.7 7.5 4.8
21 D81234 Translation-elongation factor Tu 16.9 43.1 6.3 5.1
aCoincident with proteins identified also in Neisseria lactamica.
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25 spots common to the three strains, corresponding to 34%
of the total number of spots detected in strain B16B6, 25% of
those in strain Nm30, and 22% of those in strain M982. All
common spots had molecular masses between 20 and 60 kDa,
and pI values between 5 and 8. By contrast, the software
detected only 17 common spots in the N. lactamica strains
(Fig. 1D), corresponding to 40% of the total number of spots
in strain NlP0, 19% of those in strain NlP2, and 25% of those
in strain NlP5. As in the N. meningitidis strains, many of these
spots formed a “train” at 31–34 kDa, with pI values ranging
from 5 to 10.
The reference maps (Figs. 1B, D) obtained for the com-
mon spots detected in both species were compared using the
above-described software. Only a small number of proteins
common to the two species were detected (not shown).
Identification of the main antigenic spots (see below) found in
N. meningitidis and N. lactamica by MALDI-TOF peptide
map fingerprinting revealed only five coincident proteins
(indicated in Tables 1, 2). These corresponded with ten spots
in the N. meningitidis maps and eight in the N. lactamica
maps.
Western-blotting of the proteome gels using sequential
detection with specific mAbs and the anti-P47 and anti-
OMVs sera allowed the generation of immunoproteome
maps (summarized in Fig. 2). The anti-PorA mAb reacted
with several spots in the N. meningitidis strains. The molec-
ular masses of the spots were between 31 and 41 kDa and
their pI values were variable (Fig. 2A, B). As expected, no
reaction with the anti-PorA mAb was observed in the N. lac-
tamica maps (Fig. 2C, D). The anti-RmpM mAb reacted with
spots in the N. lactamica strains that were of lower molecu-
lar mass (32–34 kDa) than those in the N. meningitidis strains
(37 kDa). RmpM spots either common to both species or
exclusive to N. meningitidis were seen. The molecular masses
of the RmpM spots differed from those reported on the basis
of one-dimensional SDS-PAGE: three of these spots were
located around 53 kDa, and another three around 19 kDa,
with pI values between 6 and 6.5 in all cases. The anti-P47
serum detected three spots in all N. meningitidis strains, with
molecular masses of 27, 43, and 56 kDa and each with a pI
of 7.2, but this serum failed to react with any spot in the N.
lactamica strains under the assay conditions used. When
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Table 2. MASCOT search results obtained by MALDI-TOF analysis of relevant spots of the N. lactamica master strain (NlP0)
Molecular mass Isoelectric point
Spot GenBank accession no. Protein name Observed Predicted Observed Predicted
1 CAA61902 Fe-regulated protein B (N. meningitidis) 72.7 79.6 6.3 9.4
2 CAB83768 Chaperonin 60-kDa subunita 63.0 57.5 7.1 5.0
3 C81021 Chaperonin 60-kDa (N. meningitidis)a 66.1 45.6 9.0 5.0
4 CAA70491 Porin 36.2 31.6 4.8 7.2
5 CAA70491 Porin 35.6 31.6 5.3 7.2
6 CAA70491 Porin 36.2 31.6 5.9 7.2
7 CAA70491 Porin 37.7 31.6 9.6 7.2
8 CAA46071 Periplasmic iron-binding proteina 29.9 34.2 8.9 9.5
9 A37004 Class 4 OMP (precursor)a 28.8 26.2 5.6 7.0
10 A37004 Class 4 OMP (precursor)a 28.8 26.2 5.8 7.0
11 A37004 Class 4 OMP (precursor)a 28.7 26.2 7.3 7.0
12 AAC44892 Hemoglobin-haptoglobin utilization protein A (N. meningitidis) 29.7 36.5 7.3 8.7
13 CAB85036 Histidine-binding periplasmic protein (N. meningitidis)a 30.1 29.0 8.7 6.0
14 AAK08056 Ex13L 29.7 47.0 5.9 4.5
15 AAW90622 Putative ABC transporter, periplasmic binding protein (N. gonorrhoeae) 26.6 30.2 6.8 6.2
16 YP_209148 Genome-derived neisserial antigen 1946 (N. gonorrhoeae) 25.7 31.4 7.6 5.3
17 AAK08056 Ex13L 23.7 47.0 6.5 4.5
18 AAF40732 Thiol:disulfide interchange protein DsbA (N. meningitidis)a 24.1 25.4 6.8 5.8
19 CAA29561 Unnamed protein product (N. gonorrhoeae) 20.3 18.7 7.0 4.7
20 AAF41888 H.8 outer-membrane protein (N. meningitidis) 20.3 18.7 7.2 4.7
aCoincident with proteins identified also in Neisseria meningitidis.
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individual immunoproteome maps from N. meningitidis and
N. lactamica were digitally compared, only nine spots com-
mon to the two species were detected (not shown).
Discussion
Proteomic approaches facilitate the identification, quantifica-
tion, and structural, biochemical and functional characteriza-
tion of proteins. They also allow the evaluation of how these
characteristics vary in space and time and with physiological
state. In the case of pathogenic microorganisms, proteomic
techniques have been extensively used to identify new bio-
markers and determinants of virulence, as well as candidate
antigens for use in vaccine development [6]. In the present
study, we constructed proteome and immunome maps of
outer-membrane proteins from different strains of N. menin-
gitidis and N. lactamica. Our immediate aim was to identify
antigens common to the two species, or exclusive to each
one, and then evaluate their potential in the development of
effective vaccines against N. meningitidis serogroup B.
The construction of such maps requires good separation of
the proteins present in the samples. Two-dimensional elec-
trophoresis, based on IEF and subsequent SDS-PAGE, yields
good protein resolution [3,19,21]. Moreover, when used in
combination with Western-blotting with specific antisera, it
is the only technique available for the construction of
immunoproteome maps in which individual antigens can be
detected and compared. However, it should be noted that
some antigenic membrane proteins cannot be analyzed due to
their extreme pI or to solubilization problems during IEF sep-
aration in the first dimension. In the present study, the best
resolution and a high reproducibility were obtained using 5 M
urea and 2 M thiourea for solubilization. Other important fac-
tors were appropriate incubation times and the use of zwitte-
rionic detergents to avoid increases in the ionic charge of the
solution, which allowed the application of high voltages
without a major increase in current. Although the detection of
OUTER MEMBRANE PROTEOMES
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Fig. 2. Immunoproteome maps of the outer-membrane antigens from N. meningitidis strains B16B6 (A) and Nm30 (B), and from
N. lactamica strains NlP2 (C) and NlP5 (D). Spots marked in the figure were identified by sequential probing with monoclonal anti-
bodies against PorA, PorB, and RmpM, and two polyclonal sera against P47 and whole OMVs.
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proteins present at low concentrations is difficult, when the
eventual aim is to detect antigenic proteins this problem is often
corrected because proteins can be distinguished with specific
antibodies. We also observed that some of the spots detected
after immunoblotting did not correspond to any of the spots
visualized in the gels by Coomassie staining.
Previous studies have revealed the complexity of OMV
proteomes, in which many periplasmic and cytosolic proteins
are present [19–21]; however, a bias toward major proteins
such as PorA, PorB, and RmpM is usually evident. We found
that the extraction of OMVs by mechanical approaches,
although more time-consuming, results in a much lower con-
tamination of OMV preparations with periplasmic and
cytosolic proteins (unpublished results) than occurs with the
method used by the authors of those other studies, in which
OMVs were obtained by detergent solubilization.
Analysis by 2D-PAGE and immunoblotting confirmed
that PorA is present in all strains of N. meningitidis but absent
in all strains of N. lactamica, as previously reported [7,20].
In the N. meningitidis maps, PorA was detected as a series of
spots (“trains”), with molecular masses between 38 and 41
kDa, that were distributed over the entire pI range analyzed.
This observation is in agreement with published studies on
the composition of OMV-based vaccines [19,21]. The train-
like distribution may have been due to many factors, such as
post-translational modifications and/or processing [21], or
the association of PorA with different membrane complexes of
varying isoelectric points that were maintained during IEF sep-
aration [13]. The anti-RpmM mAb identified several spots
with molecular masses of 35 kDa and pI values between 5.6
and 7.4. In addition, all the N. meningitidis strains analyzed
showed other spots for RmpM; their pI values were in the
range of 6–6.5, and their apparent molecular masses were 53.3
(3 spots) or 19 (3 spots) kDa. These 19-kDa forms could be
involved in the process of dimerization of RmpM, as recently
described [5]. In fact, the molecular mass of this spot coincides
with that of the C-terminal fragment of the protein, named
RmpM-Cter, which consists of an 18-kDa OmpA-like domain
able to interact with other outer-membrane proteins. The spots
of higher molecular mass identified by the antibody used in the
present study probably correspond to different conformations
of the protein or to associations with other membrane compo-
nents (PorA and/or PorB), either of which would affect its
apparent electrophoretic mobility. The anti-RmpM mAb did
not detect any of these higher or lower molecular mass spots in
any of the N. lactamica strains, which suggests that they rep-
resent forms specific to N. meningitidis. RmpM in N. lactami-
ca appeared as a series of spots with molecular masses of
32–34 kDa, in agreement with previous studies carried out in
our laboratory [17].
On the basis of computerized analysis of the results
obtained from N. meningitidis and N. lactamica, our results
indicate that different strains may show different proteomes
despite having the same protein composition. Indeed, an N.
meningitidis strain and an N. lactamica strain may have a sim-
ilarity percentage (based on coincident spots) comparable to
that between two N. meningitidis strains. Furthermore, we
have shown that there is no close correspondence between pro-
teomes and immunomes, which hinders the identification of
species-specific and shared antigens. When individual spots
are identified by MALDI-TOF, it becomes clear that observed
mobilities are very unreliable and by no means appropriate for
comparisons, even between strains of the same species.
Using image analysis to evaluate and compare the
immunome maps obtained, we were able to identify only one
antigenic protein, RmpM, common to the two species.
However, visual analysis of the results obtained with poly-
clonal sera revealed the presence of numerous other antigenic
proteins expressed in common. It is important to bear in mind
that proteins common to the two species show differences in
molecular mass, as seen in the case of RmpM. Furthermore,
proteins with high molecular masses, complex-forming pro-
teins, and highly hydrophobic proteins (many membrane pro-
teins) may not enter the gels, or may not be focused properly
during the first-dimension step. Similarly, proteins with
extreme pI values may be excluded from IEF gels, which
gives rise to very different protein or antigen patterns in the
second dimension than would be obtained by one-dimension-
al SDS-PAGE. Many antigens may thus seem to disappear or
will show anomalous patterns. Similarly, it should be borne in
mind that the solubilization conditions used in IEF are very
different from those used in one-dimensional SDS-PAGE. We
thus consider that adequate analysis of bacterial-membrane
immunoproteomes still requires research into separation tech-
niques, more efficient antigen detection, and identification by
tryptic digestion, fingerprinting, and comparison with protein
databases, already available for N. meningitidis. 
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